Nafamostat Mesylate
甲磺酸萘莫司他
Report date: 2026/05/14 20:00:28
NME
Base Information
Drug NameNafamostat Mesylate
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[7]
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved DateN/A
Country/Territory +[6]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesZhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, ChinaUniversity of ZurichYokohama City University +[5]
Inactive CompaniesEnsysce Biosciences IncChong Kun Dang Pharmaceutical CorpShandong Bestcomm Pharmaceutical Company Ltd +[4]
Active Indications +[5]
Inactive Indications